Role of triglyceride glucose index in long-term mortality of patients with lower extremity arterial disease

Biomark Med. 2022 Dec;16(17):1219-1228. doi: 10.2217/bmm-2022-0393. Epub 2023 Feb 15.

Abstract

Aim: This work was designed to explore the role of the triglyceride-glucose (TyG) index in the prediction of long-term mortality in patients with lower extremity artery disease (LEAD) undergoing endovascular revascularization. Methods: The records of 723 patients with symptomatic LEAD undergoing endovascular revascularization between January 2016 and December 2021, with long-term follow-up until December 2021, were analyzed. Results: The rate of long-term mortality was significantly higher among patients with high TyG index than patients with low TyG index. Conclusion: The TyG index is an independent predictor of long-term mortality in patients with LEAD undergoing endovascular revascularization.

Keywords: endovascular revascularization; long-term mortality; lower extremity artery disease; triglyceride-glucose index.

MeSH terms

  • Biomarkers
  • Blood Glucose
  • Glucose*
  • Humans
  • Lower Extremity
  • Risk Assessment
  • Risk Factors
  • Triglycerides
  • Vascular Diseases*

Substances

  • Glucose
  • Blood Glucose
  • Triglycerides
  • Biomarkers